It activates GLP-1, GIP and glucagon receptors to influence appetite, metabolism and energy expenditure, making it one of the most closely studied investigational weight management therapies
GIP receptor activation becomes more meaningful
These cardiovascular advantages have made GLP-1 medications a preferred choice for type 2 diabetes patients with established cardiovascular disease
The most common study treatment-related adverse effects were GI disorders such as vomiting, abdominal distention, and nausea, however, mostly of mild intensity
I reached out directly to my pharmacy, and it was fast
She opted to receive care at ER Wellness due to various trials of diet and experience programs and was not able to get rid of stubborn weight and had a decrease in energy